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Mechanism of preventive effect of HMG-CoA reductase inhib- Mitogen-activated protein kinase (MAPK) cascade is
itor on diabetic nephropathy. one of the important kinase cascades that transmit extra-
Background. Previously, we have found that pravastatin cellular stimuli to various cellular functions [2]. MAPK
prevents diabetic nephropathy in streptozotocin-induced dia-
is activated via Ras-dependent intracellular signalingbetic rats independently of serum lipid levels. The aim of this
pathway associated with tyrosine-kinase-coupled recep-study was to clarify the impact of pravastatin on the mesangial
tors [3]. Recent studies indicate that MAPK is activatedcells exposed to high glucose.
Methods. Rat mesangial cells were cultured in DMEM con- in the mesangial cells cultured under high glucose condi-
taining low glucose (5 mm glucose), high glucose (25 mm glucose) tion via activation of protein kinase C [4].
and 25 mm glucose with 500 mm pravastatin for 48 hours, respec- Previously, we have found that 3-hydroxy-3-methyl-tively. After harvesting, we examined membrane-associated
glutaryl (HMG-CoA) reductase inhibitor, pravastatin,Ras with immunoblot analysis, activity of mitogen-activated
has a preventive effect on the development of diabeticprotein kinase (MAPK) in the cytosol fraction with in-gel ki-
nase assay and expressions of TGF-b mRNA with Northern nephropathy in STZ-diabetic rats independently of se-
blot analysis. rum lipid levels [5]. HMG-CoA reductase inhibitor sup-
Results. Membrane-associated Ras, activity of MAP kinase, presses Ras-MAPK cascade by an inhibitory effect on
and expression of transforming growth factor-b (TGF-b) mRNA prenylation of Ras. Hence, we speculate that the benefi-were increased in the mesangial cells cultured exposed to high
cial effect of pravastatin on diabetic nephropathy canglucose compared to low glucose. Pravastatin suppressed all
be attributed to suppression of Ras-MAPK cascade bythese changes in membrane-associated Ras, MAP kinase and
TGF-b mRNA in high glucose. pravastatin in the glomeruli of the diabetic rats. To clarify
Conclusions. This study suggests that pravastatin suppresses the impact of pravastatin on Ras-MAPK cascade in dia-
the activity of Ras-MAP kinase cascade and induction of TGF-b betic milieu, we examined the effect of pravastatin on
in the mesangial cells that have been exposed to high glucose.
membrane-associated Ras, MAPK activity and expres-
sion of TGF-b mRNA in the rat mesangial cells cultured
in high glucose medium.
Mesangial expansion plays a crucial role in the devel-
opment of diabetic nephropathy. Additionally, alterations
METHODSin the synthesis or action of various cytokines and growth
factors have all been hypothesized to be involved in the Mesangial cells were isolated from glomeruli of male
pathogenesis of diabetic nephropathy. Recent investiga- Wistar rats (Crea, Japan) and maintained in 10 cm2 Petri
tions have revealed that transforming growth factor-beta dishes in Dulbecco’s modified Eagle medium (DMEM;
(TGF-b) is an important cytokine in the pathogenesis of Nissui, Japan) supplemented with 10% fetal bovine se-
diabetic nephropathy, up-regulating extracellular matrix rum, 50 mg/ml piperacillin Na, 100 mg/ml streptomycin
proteins synthesis in the mesangial cells. High glucose sulfate, 5 mg/ml insulin, and 2 mg/ml amphotericin B.
causes an increase in expression of TGF-b in the glomeruli Cultures were kept at 378C with 5% CO2. For passage
of streptozotocin (STZ)-diabetic rats [1]; however, the confluent cells were washed with HEPES buffer, re-
precise mechanism whereby ambient glucose stimulates moved with trypsin/EDTA (Clonetics, USA), and plated
the synthesis of TGF-b remains unknown. in DMEM. The experiments included in this study were
performed on the cells between the 5th and 7th passages.
For experiments the medium was exchanged to fresh
Key words: diabetes, HMG-CoA reductase inhibitor, Ras, provastatin. DMEM plus 0.5% fetal bovine serum containing either
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S-178
Yokota et al: Effect of pravastatin on diabetic nephropathy S-179
mm of D-glucose). We added 350 mg/dl D-mannitol to Ci/mmol, NEN, Japan) using random primer extension
kit (Takara Shuzo, Japan) or g-[32P]ATP (7000 Ci/mmol;DMEM containing low glucose to achieve an equal final
medium osmolarity as that containing high glucose. As NEN, Japan) using 59-end labeling procedure (Takara
Shuzo, Japan). Prehybridization and hybridization werean additional experiment, the cells were incubated with
high glucose medium in the presence of 500 mm pravas- performed overnight at 428C in the buffer containing
50% formamide, 5 3 SSPE, 5 3 Denhardt solution, 0.5%tatin purchased from Sankyo, Japan. After 48 hours, the
mesangial cells were harvested in ice-cold lysis buffer (5 SDS, and 100 mg/ml denatured salmon sperm DNA.
Then, the blots were washed five times in 2 3 SSC, 0.1%mmol/liter Tris-HCl, pH 7.5, 5 mmol/liter EDTA, 1
mmol/liter PMSF) and sonicated at 48C for 30 seconds. SDS at room temperature and washed with 1 3 SSC,
For immunoblot analysis cell lysates were centrifuged at 0.1% SDS at 658C for an additional 30 minutes. After
100,000 g to separate membrane fraction as precipitate. they dried, the membranes were exposed to Imaging
Resuspended membrane fractions were electrophoresed Analyzer BAS2000 (Fuji Photo Film, Japan) and each
by SDS-PAGE, followed by immunoblotting with anti- band that hybridized with the probes was detected and
H-ras monoclonal antibody (Oncogene Sci., Japan) and quantitated as a relative ratio.
imaged by the ECL-system (Amersham, Japan). The
activity of MAP kinase was measured by the in-gel kinase
RESULTSassay as previously reported [4]. Mesangial cells were
There was no difference in the levels of H-ras mRNAlysed in ice-cold lysis buffer (50 mmol/liter Tris-HCl, pH
between the mesangial cells cultured in low and high7.5, 1% Nonidet P40, 140 mmol/liter NaCl, 1 mmol/liter
glucose medium. Furthermore, addition of pravastatinsodium orthovanadate, 50 mmol/liter NaF, 1 mmol/liter
did not affect the levels of H-ras mRNA in the mesangialegtazic acid (EGTA), 1 mmol/liter PMSF, and 1 mg/ml
cells (Fig. 1A). In contrast, the amount of Ras proteinleupeptin) and sonicated at 48C for 30 seconds. Homoge-
in the membrane fractions detected by immunoblot anal-nates were centrifuged at 12,000 g at 48C for 30 minutes
ysis was increased 1.6-fold in the mesangial cells culturedand supernatants were used for the kinase assay. The
in high glucose compared to low glucose. Addition ofconcentrations of proteins in the supernatants were de-
pravastatin suppressed this increment of membrane-termined using modified Lowry assay kit (Pierce, USA).
associated Ras in the mesangial cells cultured in highFor the in-gel kinase assay lysates were applied to 10%
glucose (Fig. 1B).SDS-polyacrylamide gel containing 0.5 mg/ml myelin ba-
The activity of MAPK was increased in the mesangialsic protein (MBP) as the substrate. After electrophoresis,
cells cultured in high glucose compared to low glucose.the gels were washed to remove SDS with the buffer A
Addition of pravastatin suppressed the increment of the(50 mmol/liter HEPES, pH 7.4, and 5 mmol/liter mercap-
toethanol) containing 20% 2-propanol. The proteins in activity of MAPK in the mesangial cells cultured in high
the gel were denatured in the buffer A containing 6 mol/ glucose medium (Fig. 2A).
liter guanidinium thiocyanate at room temperature for The expression of TGF-b mRNA was elevated in the
one hour and renatured in the buffer A containing 0.04% mesangial cells cultured in high glucose compared to low
Tween-40 at 48C for 16 hours. For kinase reaction the glucose. Addition of pravastatin suppressed the induc-
gels were incubated at 308C for one hour in the buffer tion of TGF-b mRNA in the mesangial cells cultured in
A containing 50 mmol/liter ATP and 250 mCi g-[32P] aden- high glucose medium (Fig. 2B).
osine 59-triphosphate (ATP). The gels were washed with
5% trichloroacetic acid and 10 mmol/liter sodium pyro-
DISCUSSIONphosphate and followed by densitometric analysis with
This study has revealed that ambient high glucose up-Imaging Analyzer BAS2000 (Fuji Photo Film, Japan).
regulates the translocation of Ras to the cell membraneFor Northern blot analysis, the cells were lysed with 4
from the cytosol without influence on transcription ofmol/liter guanidinium thiocyanate containing 25 mmol/
Ras gene and that pravastatin suppresses the exagger-liter sodium citrate, pH 7.0, 0.5% sarcosyl, and 0.1 mmol/
ated translocation of Ras in high glucose medium. Rasliter 2-b-mercaptoethanol. Total RNA was isolated by
receives post-translational modification, prenylation, co-the single-step method, using phenol and chloroform/
valently binding farnesyl or geranylgeranyl group, bothisoamyl alcohol [6]. Electrophoresis of 20 mg of total
of which are intermediate metabolites of cholesterol syn-RNA was carried out in 1% agarose gel with 2.2 mmol/
thesis. Prenylated Ras attaches to the cell membrane vialiter formaldehyde. The RNA was then transferred over-
these hydrophobic groups, which make Ras capable ofnight onto a nylon membrane (Amersham, Japan). The
mediating signal transduction associated with tyrosine-cDNA probes used in this study were v-H-ras (Takara
kinase-coupled receptor [7]. HMG-CoA reductase inhib-Shuzo, Japan), rat TGF-b1 (gift of Dr. H. Kurata), and
itor may suppress the activity of Ras by its inhibitorythe rat GAPDH cDNA (Oncogene Research Product,
Japan). The cDNAs were labeled with a-[32P]dCTP (3000 effect on prenylation. O’Donnell et al reported that
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Fig. 1. Influence of high glucose and pravastatin on the expression of H-ras mRNA (A) and the amount of Ras protein in membrane fractions
(B) in cultured rat mesangial cells. Cells were treated as described in the Methods section. The culture media were replaced with low glucose (5
mm) media (a), high glucose (25 mm) media (b) or high glucose media containing 500 mm pravastatin (p). The cells were harvested at 48 hours
after exchange of culture media. Total cellular RNA was extracted for Northern blot analysis performed with 32P-labeled H-ras and GAPDH
cDNAs. Ras protein in membrane fraction was detected by immunoblot analysis with H-ras monoclonal antibody and imaged by an enhanced
chemiluminescence system. Recombinant H-ras was used as a standard. The values represent the means of triplicate experiments and are expressed
as relative ratio.
HMG-CoA reductase inhibitor, lovastatin, suppresses gest that downstream of platelet-derived growth factor
(PDGF) the b receptor may involve translocation ofthe proliferation of cultured mesangial cells stimulated
by fresh serum inhibiting farnesylation of Ras [8]. The Grb2/Sos complex leading to an activation of Ras [9].
To prove the possibility of PDGF-BB as a candidate ofpresent experiment also suggests that the effect of pra-
vastatin is involved in prenylation of Ras, which may be triggering Ras-MAPK cascade, we examined the influ-
ence of high glucose on the expression of PDGF-Baccelerated in the mesangial cells cultured in high glu-
cose medium. mRNA in cultured rat mesangial cells [10]. We found
that the expression of PDGF-B mRNA is increased inIn the present experiment, the activity of MAPK and
the expression of TGF-b mRNA were simultaneously the mesangial cells cultured in high glucose compared
to low glucose. Therefore, it is possible that PDGF-BBenhanced in the mesangial cells cultured in high glucose
compared to low glucose. Pravastatin significantly sup- activates Ras in an autocrine manner via the PDGF-b
receptor in the mesangial cells exposed to high glucose;pressed the activity of MAPK and the expression of
TGF-b mRNA induced in the mesangial cells cultured however, further examination is required to prove this
hypothesis.in high glucose medium. These data suggest that activity
of MAPK plays a crucial role in the transcriptional regu- On the basis of these data, we conclude that activation
of Ras-MAPK cascade is responsible for induction oflation of TGF-b gene in the mesangial cells, and that
pravastatin suppresses Ras-MAPK cascade that is en- transcription of TGF-b in the mesangial cells cultured
in high glucose medium, and that HMG-CoA reductasehanced by ambient high glucose.
What factor(s) or receptor(s) promotes the Ras-MAPK inhibitor, pravastatin, suppresses the expression of TGF-b
through its inhibitory effect on Ras-MAPK cascade, whichcascade in mesangial cells exposed to high glucose re-
mains to be determined. Recent investigations sug- results in the prevention of diabetic nephropathy.
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Fig. 2. Influence of high glucose and pravastatin on the activity of MAPK (A) and the expression of TGF-b mRNA (B) in cultured rat mesangial
cells. Cells were treated as described in the Methods section. The culture media were replaced with low glucose (5 mm) media (a), high glucose
(25 mm) media (b), high glucose media containing 500 mm pravastatin (p). The cells were harvested at 48 hours after exchange of culture media.
The activity of MAPK was determined by the in-gel kinase assay. Total cellular RNA was extracted for Northern blot analysis performed with
32P-labeled TGF-b and GAPDH cDNAs. The relative kinase activities of MAPK and the relative intensities of TGF-b mRNA bands are shown.
Values are expressed as mean 6 sd of three experiments (*P , 0.05 versus low glucose).
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